Global Bipolar Disorder Therapeutics Drugs Market Research Report 2021

Publisher Name :
Date: 02-Mar-2021
No. of pages: 115
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Olanzapine (Zyprexa)

- Quetiapine (Seroquel)

- Risperidone (Risperdal)

- Ariprazole (Abilify)

- Ziprasidone (Geodon)

- Clozapine (Clozaril)

Segment by Application

- lumateperone

- Central Nervous System (CNS) Disorders

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- AstraZeneca

- Allergan

- Bristol-Myers Squibb

- GSK

- Janssen

- AbbVie

- Youdim

- Delpor

- Lundbeck

- Intra-Cellular Therapies

- Novartis Pharmaceuticals Corporation

- Noven Pharmaceuticals

- Otsuka

- Pfizer

- Reviva Pharmaceuticals

Global Bipolar Disorder Therapeutics Drugs Market Research Report 2021

Table of Contents
1 Bipolar Disorder Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Bipolar Disorder Therapeutics Drugs
1.2 Bipolar Disorder Therapeutics Drugs Segment by Type
1.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Olanzapine (Zyprexa)
1.2.3 Quetiapine (Seroquel)
1.2.4 Risperidone (Risperdal)
1.2.5 Ariprazole (Abilify)
1.2.6 Ziprasidone (Geodon)
1.2.7 Clozapine (Clozaril)
1.3 Bipolar Disorder Therapeutics Drugs Segment by Application
1.3.1 Bipolar Disorder Therapeutics Drugs Sales Comparison by Application: (2021-2027)
1.3.2 lumateperone
1.3.3 Central Nervous System (CNS) Disorders
1.4 Global Bipolar Disorder Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Bipolar Disorder Therapeutics Drugs Revenue 2016-2027
1.4.2 Global Bipolar Disorder Therapeutics Drugs Sales 2016-2027
1.4.3 Bipolar Disorder Therapeutics Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Bipolar Disorder Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Bipolar Disorder Therapeutics Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Bipolar Disorder Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Bipolar Disorder Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Bipolar Disorder Therapeutics Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Bipolar Disorder Therapeutics Drugs Players Market Share by Revenue
2.5.3 Global Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bipolar Disorder Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Bipolar Disorder Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Bipolar Disorder Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Bipolar Disorder Therapeutics Drugs Sales by Country
3.3.2 North America Bipolar Disorder Therapeutics Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Country
3.4.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Bipolar Disorder Therapeutics Drugs Sales by Country
3.6.2 Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Bipolar Disorder Therapeutics Drugs Historic Market Analysis by Type
4.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2021)
4.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Bipolar Disorder Therapeutics Drugs Price by Type (2016-2021)
5 Global Bipolar Disorder Therapeutics Drugs Historic Market Analysis by Application
5.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2021)
5.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Bipolar Disorder Therapeutics Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AstraZeneca Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Allergan Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Corporation Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bristol-Myers Squibb Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GSK Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Janssen
6.5.1 Janssen Corporation Information
6.5.2 Janssen Description and Business Overview
6.5.3 Janssen Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Janssen Product Portfolio
6.5.5 Janssen Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Corporation Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 AbbVie Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
6.7 Youdim
6.6.1 Youdim Corporation Information
6.6.2 Youdim Description and Business Overview
6.6.3 Youdim Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Youdim Product Portfolio
6.7.5 Youdim Recent Developments/Updates
6.8 Delpor
6.8.1 Delpor Corporation Information
6.8.2 Delpor Description and Business Overview
6.8.3 Delpor Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Delpor Product Portfolio
6.8.5 Delpor Recent Developments/Updates
6.9 Lundbeck
6.9.1 Lundbeck Corporation Information
6.9.2 Lundbeck Description and Business Overview
6.9.3 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Lundbeck Product Portfolio
6.9.5 Lundbeck Recent Developments/Updates
6.10 Intra-Cellular Therapies
6.10.1 Intra-Cellular Therapies Corporation Information
6.10.2 Intra-Cellular Therapies Description and Business Overview
6.10.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Intra-Cellular Therapies Product Portfolio
6.10.5 Intra-Cellular Therapies Recent Developments/Updates
6.11 Novartis Pharmaceuticals Corporation
6.11.1 Novartis Pharmaceuticals Corporation Corporation Information
6.11.2 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Description and Business Overview
6.11.3 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Novartis Pharmaceuticals Corporation Product Portfolio
6.11.5 Novartis Pharmaceuticals Corporation Recent Developments/Updates
6.12 Noven Pharmaceuticals
6.12.1 Noven Pharmaceuticals Corporation Information
6.12.2 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Description and Business Overview
6.12.3 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Noven Pharmaceuticals Product Portfolio
6.12.5 Noven Pharmaceuticals Recent Developments/Updates
6.13 Otsuka
6.13.1 Otsuka Corporation Information
6.13.2 Otsuka Bipolar Disorder Therapeutics Drugs Description and Business Overview
6.13.3 Otsuka Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Otsuka Product Portfolio
6.13.5 Otsuka Recent Developments/Updates
6.14 Pfizer
6.14.1 Pfizer Corporation Information
6.14.2 Pfizer Bipolar Disorder Therapeutics Drugs Description and Business Overview
6.14.3 Pfizer Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Pfizer Product Portfolio
6.14.5 Pfizer Recent Developments/Updates
6.15 Reviva Pharmaceuticals
6.15.1 Reviva Pharmaceuticals Corporation Information
6.15.2 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Description and Business Overview
6.15.3 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Reviva Pharmaceuticals Product Portfolio
6.15.5 Reviva Pharmaceuticals Recent Developments/Updates
7 Bipolar Disorder Therapeutics Drugs Manufacturing Cost Analysis
7.1 Bipolar Disorder Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Bipolar Disorder Therapeutics Drugs
7.4 Bipolar Disorder Therapeutics Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Bipolar Disorder Therapeutics Drugs Distributors List
8.3 Bipolar Disorder Therapeutics Drugs Customers
9 Bipolar Disorder Therapeutics Drugs Market Dynamics
9.1 Bipolar Disorder Therapeutics Drugs Industry Trends
9.2 Bipolar Disorder Therapeutics Drugs Growth Drivers
9.3 Bipolar Disorder Therapeutics Drugs Market Challenges
9.4 Bipolar Disorder Therapeutics Drugs Market Restraints
10 Global Market Forecast
10.1 Bipolar Disorder Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Bipolar Disorder Therapeutics Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Bipolar Disorder Therapeutics Drugs by Type (2022-2027)
10.2 Bipolar Disorder Therapeutics Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Bipolar Disorder Therapeutics Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Bipolar Disorder Therapeutics Drugs by Application (2022-2027)
10.3 Bipolar Disorder Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Bipolar Disorder Therapeutics Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Bipolar Disorder Therapeutics Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Bipolar Disorder Therapeutics Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Bipolar Disorder Therapeutics Drugs Covered in This Study
Table 5. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Bipolar Disorder Therapeutics Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Bipolar Disorder Therapeutics Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Bipolar Disorder Therapeutics Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Bipolar Disorder Therapeutics Drugs Product Type
Table 12. Global Bipolar Disorder Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Bipolar Disorder Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Bipolar Disorder Therapeutics Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Bipolar Disorder Therapeutics Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2016-2021)
Table 42. Global Bipolar Disorder Therapeutics Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Bipolar Disorder Therapeutics Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2016-2021)
Table 47. Global Bipolar Disorder Therapeutics Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Business Overview
Table 50. AstraZeneca Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. AstraZeneca Bipolar Disorder Therapeutics Drugs Product
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Allergan Corporation Information
Table 54. Allergan Description and Business Overview
Table 55. Allergan Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Allergan Bipolar Disorder Therapeutics Drugs Product
Table 57. Allergan Recent Developments/Updates
Table 58. Bristol-Myers Squibb Corporation Information
Table 59. Bristol-Myers Squibb Description and Business Overview
Table 60. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product
Table 62. Bristol-Myers Squibb Recent Developments/Updates
Table 63. GSK Corporation Information
Table 64. GSK Description and Business Overview
Table 65. GSK Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. GSK Bipolar Disorder Therapeutics Drugs Product
Table 67. GSK Recent Developments/Updates
Table 68. Janssen Corporation Information
Table 69. Janssen Description and Business Overview
Table 70. Janssen Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Janssen Bipolar Disorder Therapeutics Drugs Product
Table 72. Janssen Recent Developments/Updates
Table 73. AbbVie Corporation Information
Table 74. AbbVie Description and Business Overview
Table 75. AbbVie Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. AbbVie Bipolar Disorder Therapeutics Drugs Product
Table 77. AbbVie Recent Developments/Updates
Table 78. Youdim Corporation Information
Table 79. Youdim Description and Business Overview
Table 80. Youdim Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Youdim Bipolar Disorder Therapeutics Drugs Product
Table 82. Youdim Recent Developments/Updates
Table 83. Delpor Corporation Information
Table 84. Delpor Description and Business Overview
Table 85. Delpor Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Delpor Bipolar Disorder Therapeutics Drugs Product
Table 87. Delpor Recent Developments/Updates
Table 88. Lundbeck Corporation Information
Table 89. Lundbeck Description and Business Overview
Table 90. Lundbeck Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Lundbeck Bipolar Disorder Therapeutics Drugs Product
Table 92. Lundbeck Recent Developments/Updates
Table 93. Intra-Cellular Therapies Corporation Information
Table 94. Intra-Cellular Therapies Description and Business Overview
Table 95. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product
Table 97. Intra-Cellular Therapies Recent Developments/Updates
Table 98. Novartis Pharmaceuticals Corporation Corporation Information
Table 99. Novartis Pharmaceuticals Corporation Description and Business Overview
Table 100. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product
Table 102. Novartis Pharmaceuticals Corporation Recent Developments/Updates
Table 103. Noven Pharmaceuticals Corporation Information
Table 104. Noven Pharmaceuticals Description and Business Overview
Table 105. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product
Table 107. Noven Pharmaceuticals Recent Developments/Updates
Table 108. Otsuka Corporation Information
Table 109. Otsuka Description and Business Overview
Table 110. Otsuka Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Otsuka Bipolar Disorder Therapeutics Drugs Product
Table 112. Otsuka Recent Developments/Updates
Table 113. Pfizer Corporation Information
Table 114. Pfizer Description and Business Overview
Table 115. Pfizer Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Pfizer Bipolar Disorder Therapeutics Drugs Product
Table 117. Pfizer Recent Developments/Updates
Table 118. Reviva Pharmaceuticals Corporation Information
Table 119. Reviva Pharmaceuticals Description and Business Overview
Table 120. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product
Table 122. Reviva Pharmaceuticals Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Bipolar Disorder Therapeutics Drugs Distributors List
Table 126. Bipolar Disorder Therapeutics Drugs Customers List
Table 127. Bipolar Disorder Therapeutics Drugs Market Trends
Table 128. Bipolar Disorder Therapeutics Drugs Growth Drivers
Table 129. Bipolar Disorder Therapeutics Drugs Market Restraints
Table 130. Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 131. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 135. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 139. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bipolar Disorder Therapeutics Drugs
Figure 2. Global Bipolar Disorder Therapeutics Drugs Market Share by Type in 2020 & 2027
Figure 3. Olanzapine (Zyprexa) Product Picture
Figure 4. Quetiapine (Seroquel) Product Picture
Figure 5. Risperidone (Risperdal) Product Picture
Figure 6. Ariprazole (Abilify) Product Picture
Figure 7. Ziprasidone (Geodon) Product Picture
Figure 8. Clozapine (Clozaril) Product Picture
Figure 9. Global Bipolar Disorder Therapeutics Drugs Market Share by Application in 2020 & 2027
Figure 10. lumateperone
Figure 11. Central Nervous System (CNS) Disorders
Figure 12. Global Bipolar Disorder Therapeutics Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bipolar Disorder Therapeutics Drugs Market Size 2016-2027 (US$ Million)
Figure 14. Global Bipolar Disorder Therapeutics Drugs Sales 2016-2027 (K Units)
Figure 15. Global Bipolar Disorder Therapeutics Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Bipolar Disorder Therapeutics Drugs Sales Share by Manufacturers in 2020
Figure 17. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Bipolar Disorder Therapeutics Drugs Players: Market Share by Revenue in 2020
Figure 19. Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2016-2021)
Figure 21. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region in 2020
Figure 22. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Figure 23. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region in 2020
Figure 24. U.S. Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Bipolar Disorder Therapeutics Drugs by Type (2016-2021)
Figure 49. Sales Market Share of Bipolar Disorder Therapeutics Drugs by Application (2016-2021)
Figure 50. Sales Market Share of Bipolar Disorder Therapeutics Drugs by Application in 2020
Figure 51. Revenue Share of Bipolar Disorder Therapeutics Drugs by Application (2016-2021)
Figure 52. Revenue Share of Bipolar Disorder Therapeutics Drugs by Application in 2020
Figure 53. Manufacturing Cost Structure of Bipolar Disorder Therapeutics Drugs
Figure 54. Manufacturing Process Analysis of Bipolar Disorder Therapeutics Drugs
Figure 55. Bipolar Disorder Therapeutics Drugs Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global Clozapine Sales Market Report 2021
    Published: 15-Apr-2021        Price: US 4000 Onwards        Pages: 149
    The global Clozapine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clozapine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Tablet - Oral Suspension - By type?tablet is the m......
  • Post-pandemic Era - Global Codeine Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 114
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Codeine Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 112
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Codeine Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 97
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Codeine growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions i......
  • Post-pandemic Era - Global Haloperidol Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 102
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Haloperidol Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 104
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Haloperidol Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 85
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Haloperidol growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regio......
  • Global Trazodone Hydrochloride (API) Market Research Report 2021
    Published: 12-Apr-2021        Price: US 2900 Onwards        Pages: 105
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Trazodone Hydrochloride (API) - Others Segment by Application - Antidepression - Anxi......
  • Global Olanzapine Sales Market Report 2021
    Published: 07-Apr-2021        Price: US 4000 Onwards        Pages: 144
    The global Olanzapine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Olanzapine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Patent - Generics Segment by Application......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs